165 related articles for article (PubMed ID: 28325698)
1. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698
[TBL] [Abstract][Full Text] [Related]
2. The impact of incident depression on medication adherence in patients with type 2 diabetes.
Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
Diabetes Metab; 2017 Dec; 43(6):521-528. PubMed ID: 28822618
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study.
Lunghi C; Moisan J; Grégoire JP; Guénette L
Medicine (Baltimore); 2016 May; 95(21):e3514. PubMed ID: 27227919
[TBL] [Abstract][Full Text] [Related]
4. The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs.
Lunghi C; Moisan J; Grégoire JP; Guénette L
Value Health; 2017 Jun; 20(6):728-735. PubMed ID: 28577689
[TBL] [Abstract][Full Text] [Related]
5. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
[TBL] [Abstract][Full Text] [Related]
6. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.
Simpson SH; Lin M; Eurich DT
Ann Pharmacother; 2016 Sep; 50(9):741-6. PubMed ID: 27307411
[TBL] [Abstract][Full Text] [Related]
7. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
[TBL] [Abstract][Full Text] [Related]
8. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
An J; Nichol MB
Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
[TBL] [Abstract][Full Text] [Related]
9. Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance.
Guénette L; Moisan J; Breton MC; Sirois C; Grégoire JP
Diabetes Metab; 2013 May; 39(3):250-7. PubMed ID: 23523643
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments.
Guénette L; Breton MC; Guillaumie L; Lauzier S; Grégoire JP; Moisan J
J Diabetes Complications; 2016 Mar; 30(2):335-42. PubMed ID: 26615905
[TBL] [Abstract][Full Text] [Related]
11. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
[TBL] [Abstract][Full Text] [Related]
12. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
Sun P; Lian J
Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
[TBL] [Abstract][Full Text] [Related]
13. Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes.
Reach G; Pellan M; Crine A; Touboul C; Ciocca A; Djoudi Y
Diabetes Metab; 2018 Dec; 44(6):500-507. PubMed ID: 30031714
[TBL] [Abstract][Full Text] [Related]
14. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
Cheong C; Barner JC; Lawson KA; Johnsrud MT
Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
[TBL] [Abstract][Full Text] [Related]
15. Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalization.
Zongo A; Grégoire JP; Moisan J; Guénette L
Res Social Adm Pharm; 2019 Jun; 15(6):738-743. PubMed ID: 30253976
[TBL] [Abstract][Full Text] [Related]
16. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
17. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
[TBL] [Abstract][Full Text] [Related]
18. Persistence and adherence to oral antidiabetics: a population-based cohort study.
Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
Acta Diabetol; 2015 Jun; 52(3):547-56. PubMed ID: 25524433
[TBL] [Abstract][Full Text] [Related]
19. [Factors associated with medication non-adherence in patients with type 2 diabetes mellitus: The first Algerian survey].
Achouri MY; Mammeri M; Sehanine Y; Selka MA; Ghomari WI; Lahmer A; Hadj Habib M
Ann Pharm Fr; 2019 Nov; 77(6):506-515. PubMed ID: 31564421
[TBL] [Abstract][Full Text] [Related]
20. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
